| | | | | | | | | | |
|
|
|
|
| Dockets Entered
On December 19, 2007
|
|
|
|
|
|
|
|
|
|
|
| Docket #
|
| Title
|
|
|
|
|
|
|
| 1980N-0280
|
| Vaginal Contraceptive Drug Products for OTC Use
|
|
|
|
|
| 2000P-1211
|
| Establish Mandatory Pre-Market Safety Testing for GE Foods
|
|
|
|
|
| 2004N-0226
|
| Food and Drug Administration Modernization Act of 1997: Modifications to the List of Recognized Standards, Recognition List Number: 010
|
|
|
|
|
| 2006P-0394
|
| Revise the labeling requirements for eggs sold in the United States
|
|
|
|
|
| 2007M-0285
|
| P040044/S001 - Mynx Vascular Closure System
|
|
|
|
|
| 2007M-0286
|
| P050016 - Cormet Hip Resurfacing System
|
|
|
|
|
| 2007M-0287
|
| P050039 - Novation Ceramic Articulation Hip System
|
|
|
|
|
| 2007M-0288
|
| P930016/S025 - VISX STAR S4 IR Excimer Laser System with Variable Spot Scanning (VSS) and WaveScan WaveFront System
|
|
|
|
|
| 2007M-0289
|
| P060018 - PRESTIGE Cervical Disc System
|
|
|
|
|
| 2007M-0298
|
| P060002 - FLAIR Endovascular Stent Graft
|
|
|
|
|
| 2007M-0303
|
| P050024 - CryoCor CryoAblation System
|
|
|
|
|
| 2007M-0344
|
| P050043 - Femoral Introducer Sheath and Hemostasis (FISH) Device 5, 6, and 8 French
|
|
|
|
|
| 2007N-0262
|
| Use of Ozone-Depleting Substances; Removal of Essential-Use Designation (Epinephrine)
|
|
|
|
|
| 2007N-0356
|
| BEHIND THE COUNTER AVAILABILITY OF CERTAIN DRUGS; Public Meeting
|
|
|
|
|
| 2007N-0471
|
| Cellular, Tissue and Gene Therapies Advisory Committee; Notice of Meeting
|
|
| |
|
| 1980N-0280
|
| Vaginal Contraceptive Drug Products for OTC Use
|
|
|
|
|
| NFR 3
|
| FDA
|
| Vol #:
|
| 1
|
|
|
|
|
| 2000P-1211
|
| Establish Mandatory Pre-Market Safety Testing for GE Foods
|
|
|
|
|
| C 12998
|
| Virginia Frederick
|
| Vol #:
|
| 807
|
|
|
|
|
| 2004N-0226
|
| Food and Drug Administration Modernization Act of 1997: Modifications to the List of Recognized Standards, Recognition List Number: 010
|
|
|
|
|
| N 10
|
| FDA
|
| Vol #:
|
| 1
|
|
|
|
|
| 2006P-0394
|
| Revise the labeling requirements for eggs sold in the United States
|
|
|
|
|
| C 512
|
| Jennifer Christenson
|
| Vol #:
|
| 14
|
|
|
|
|
| C 513
|
| Michelle Sinden
|
| Vol #:
|
| 14
|
|
|
|
|
| C 514
|
| Liliana Williams
|
| Vol #:
|
| 14
|
|
|
|
|
| C 515
|
| Frank and Mary Hoffman
|
| Vol #:
|
| 14
|
|
|
|
|
| C 516
|
| Ann Mallow
|
| Vol #:
|
| 14
|
|
|
|
|
| C 517
|
| John Winston
|
| Vol #:
|
| 14
|
|
|
|
|
| 2007M-0285
|
| P040044/S001 - Mynx Vascular Closure System
|
|
|
|
|
| NAL 1
|
| FDA
|
| Vol #:
|
| 1
|
|
|
|
|
| 2007M-0286
|
| P050016 - Cormet Hip Resurfacing System
|
|
|
|
|
| NAL 1
|
| FDA
|
| Vol #:
|
| 1
|
|
| | | | | | | | |
|
| |
|
| 2007M-0287
|
| P050039 - Novation Ceramic Articulation Hip System
|
|
|
|
|
| NAL 1
|
| FDA
|
| Vol #:
|
| 1
|
|
|
|
|
| 2007M-0288
|
| P930016/S025 - VISX STAR S4 IR Excimer Laser System with Variable Spot Scanning (VSS) and WaveScan WaveFront System
|
|
|
|
|
| NAL 1
|
| FDA
|
| Vol #:
|
| 1
|
|
| |
|
| 2007M-0289
|
| P060018 - PRESTIGE Cervical Disc System
|
|
|
|
|
| NAL 1
|
| FDA
|
| Vol #:
|
| 1
|
|
|
|
|
| 2007M-0298
|
| P060002 - FLAIR Endovascular Stent Graft
|
|
|
|
|
| NAL 1
|
| FDA
|
| Vol #:
|
| 1
|
|
|
|
|
| 2007M-0303
|
| P050024 - CryoCor CryoAblation System
|
|
|
|
|
| NAL 1
|
| FDA
|
| Vol #:
|
| 1
|
|
|
|
|
| 2007M-0344
|
| P050043 - Femoral Introducer Sheath and Hemostasis (FISH) Device 5, 6, and 8 French
|
|
|
|
|
| NAL 1
|
| FDA
|
| Vol #:
|
| 1
|
|
|
|
|
| 2007N-0262
|
| Use of Ozone-Depleting Substances; Removal of Essential-Use Designation (Epinephrine)
|
|
|
|
|
| C 10
|
| Amphastar Pharmaceuticals, Inc.
|
| Vol #:
|
| 1
|
|
|
|
|
| 2007N-0356
|
| BEHIND THE COUNTER AVAILABILITY OF CERTAIN DRUGS; Public Meeting
|
|
|
|
|
| TR 1
|
| FDA
|
| Vol #:
|
| 4
|
|
|
|
|
| TR 2
|
| FDA
|
| Vol #:
|
| 4
|
|
| |
|
| 2007N-0471
|
| Cellular, Tissue and Gene Therapies Advisory Committee; Notice of Meeting
|
|
|
|
|
| NM 1
|
| FDA
|
| Vol #:
|
| 1
|
|
